Sotio PPF Group Company
Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.
Technology:
CAR-T, CAR-T therapy, Peptides and Proteins
Industry:
Private
Headquarters:
Prague, Hlavni mesto Praha, Czech Republic
Founded Date:
2010-01-01
Employees Number:
251-500
Funding Status:
Venture
Investors Number:
1
Total Funding:
316900000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-12-02
Last Funding Type:
Venture Round
Register and Claim Ownership